TABLE 1
FROM:
Transpupillary thermotherapy for subfoveal leaks in central serous chorioretinopathy
D Shukla, C Kolluru, T P Vignesh, S Karthikprakash and R Kim
BACK TO ARTICLETable 1. Cases: demographics, treatment, and follow-up
| S.N. | Age (years) | Sex | Duration (months) | Previous episode | Previous treatment | Pre-TTT VA | Repeat-TTT | Final BCVA | Follow-up (months) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 40 | M | 9 | + | + | 20/60 | - | 20/20 | 6 |
| 2 | 56 | F | 6 | - | - | 20/40 | - | 20/20 | 12 |
| 3 | 52 | M | 7 | - | - | 20/30 | - | 20/20 | 6 |
| 4 | 59 | M | 6 | + | + | 20/30 | - | 20/20 | 12 |
| 5 | 43 | M | 4 | - | - | 20/200 | - | 20/20 | 6 |
| 6 | 45 | F | 5 | - | - | 20/30 | - | 20/20 | 6 |
| 7 | 54 | M | 4 | + | - | 20/40 | + | 20/20 | 6 |
| 8 | 31 | M | 6 | + | + | 20/60 | - | 20/20 | 6a |
| 9 | 54 | M | 4 | - | - | 20/60 | - | 20/60 | 6 |
| 10 | 33 | M | 6 | - | - | 20/40 | - | 20/20 | 6 |
| 11 | 35 | M | 4 | - | - | 20/80 | - | 20/20 | 6 |
| 12 | 37 | M | 4 | - | - | 20/60 | - | 20/30 | 6 |
| 13 | 39 | M | 7 | - | - | 20/40 | - | 20/20 | 6 |
| 14 | 43 | M | 4 | + | - | 20/60 | - | 20/30 | 6 |
| 15 | 42 | M | 4 | - | - | 20/200 | - | 20/60 | 6 |
| 16 | 31 | F | 5 | - | - | 20/80 | - | 20/20 | 6 |
| 17 | 46 | M | 4 | + | - | 20/120 | - | 20/20 | 6 |
| 18 | 47 | M | 5 | - | - | 20/60 | - | 20/20 | 6 |
| 19 | 39 | M | 7 | - | - | 20/40 | - | 20/30 | 6 |
| 20 | 42 | M | 8 | + | - | 20/40 | - | 20/20 | 6 |
| 21 | 30 | M | 4 | - | - | 20/120 | - | 20/20 | 6 |
| 22 | 27 | M | 4 | - | - | 20/200 | - | 20/20 | 6 |
| 23 | 47 | M | 6 | - | - | 20/60 | - | 20/20 | 6 |
| 24 | 35 | M | 7 | - | - | 20/60 | - | 20/30 | 6 |
| 25 | 38 | M | 5 | + | + | 20/60 | - | 20/60 | 6 |
BCVA, best-corrected visual acuity; TTT, transpupillary thermotherapy; M, male; F, female; VA, visual activity.
a This patient developed a subfoveal CNV which was treated again by TTT.
